A body of research has indicated that a decline in FOXO3 levels in the muscles of the elderly is associated with an elevated risk of sarcopenia, while the activation of FOXO3 has been demonstrated to counteract the process of muscle aging [67]. Here, FOXO3 is linked to sarcopenia.